<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02769247</url>
  </required_header>
  <id_info>
    <org_study_id>384645-5</org_study_id>
    <nct_id>NCT02769247</nct_id>
  </id_info>
  <brief_title>Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion</brief_title>
  <official_title>Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Walter Reed National Military Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Walter Reed National Military Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of intrauterine lidocaine and oral naproxen sodium on discomfort and
      pain of patients undergoing intrauterine device insertion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, double-blind, placebo-controlled study with women that will be
      recruited from our outpatient obstetrics and gynecology clinic. Women desiring intrauterine
      device insertion will be invited to participate.

      The investigators plan to recruit women desiring intrauterine device insertion into one of
      four groups: A: placebo/normal saline infusion; B: placebo/lidocaine infusion; C: Saline
      infusion/ naproxen; D: lidocaine infusion/ naproxen.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2014</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Control With IUD Insertion</measure>
    <time_frame>within 30 minutes after IUD insertion</time_frame>
    <description>visual analog scale (0-10) as assessed by patient within 30 minutes after IUD insertion. Scale is from a minimum of 0, with maximum of 10 with higher scores denoting more pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physician Perceived Pain Control During IUD Insertion</measure>
    <time_frame>within 30 minutes after IUD insertion</time_frame>
    <description>visual analog scale (0-3) as assessed by physician within 30 minutes after IUD insertion Scale is from a minimum of 0, with maximum of 3 with higher scores denoting more pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction With IUD</measure>
    <time_frame>30 days post insertion</time_frame>
    <description>Patient satisfaction as rated on a 1-5 scale 30 days post insertion. Scale of 5 means highly satisfied, 1 means unsatisfied.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulty IUD Insertion</measure>
    <time_frame>within 30 minutes of IUD insertion</time_frame>
    <description>as rated by the physician. Very easy/easy were rated as &quot;easy&quot; whereas difficult/very difficult is difficult.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived Pain 30 Days Post Insertion</measure>
    <time_frame>30 days post IUD insertion</time_frame>
    <description>survey patient 30 days later to determine her recollection of pain during insertion (0-10); 10 being the most pain. One patient had no IUD initially inserted and was not included; each arm had patients lost to follow up (3 in placebo arm, 2 in naproxen arm, 4 in placebo/oral medication arm).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Contraception</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Naproxen/Normal saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo oral medication/Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Naproxen/Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naproxen</intervention_name>
    <description>Oral naproxen vs placebo</description>
    <arm_group_label>Naproxen/Lidocaine</arm_group_label>
    <arm_group_label>Naproxen/Normal saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Intrauterine lidocaine vs normal saline</description>
    <arm_group_label>Naproxen/Lidocaine</arm_group_label>
    <arm_group_label>Placebo oral medication/Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>either normal saline or empty oral capsule</description>
    <arm_group_label>Naproxen/Normal saline</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Placebo oral medication/Lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DEERS-eligible reproductive age women (i.e. Tricare beneficiaries)

          -  age 18 years and older

          -  desiring Paragard or Mirena intrauterine device insertion

        Exclusion Criteria:

          -  Current pregnancy

          -  cervical stenosis

          -  severe medical illness

          -  known allergy or sensitivity to lidocaine or naproxen

          -  peptic ulcer disease

          -  current pelvic inflammatory disease

          -  patients with known renal insufficiency

          -  patients using chronic NSAIDs or on chronic pain medication

          -  women desiring Skyla IUD insertion will also be excluded due to infrequency of
             insertions at WRNMMC
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Dunlow, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>WRNMMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>May 6, 2016</study_first_submitted>
  <study_first_submitted_qc>May 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2016</study_first_posted>
  <results_first_submitted>June 21, 2018</results_first_submitted>
  <results_first_submitted_qc>October 10, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">November 8, 2018</results_first_posted>
  <last_update_submitted>October 10, 2018</last_update_submitted>
  <last_update_submitted_qc>October 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>naproxen</keyword>
  <keyword>lidocaine</keyword>
  <keyword>intrauterine device</keyword>
  <keyword>IUD</keyword>
  <keyword>pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naproxen</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion
placebo: either normal saline or empty oral capsule</description>
        </group>
        <group group_id="P2">
          <title>Naproxen/Normal Saline</title>
          <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion
Naproxen: Oral naproxen vs placebo
placebo: either normal saline or empty oral capsule</description>
        </group>
        <group group_id="P3">
          <title>Placebo Oral Medication/Lidocaine</title>
          <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion
Lidocaine: Intrauterine lidocaine vs normal saline
placebo: either normal saline or empty oral capsule</description>
        </group>
        <group group_id="P4">
          <title>Naproxen/Lidocaine</title>
          <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion
Naproxen: Oral naproxen vs placebo
Lidocaine: Intrauterine lidocaine vs normal saline</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="40"/>
                <participants group_id="P4" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="38">unable to insert IUD in one patient; 1 pt decided against study participation after enrollment</participants>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="39">1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)</participants>
                <participants group_id="P4" count="39">1 patient decided against study participation after enrollment/randomization</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion
placebo: either normal saline or empty oral capsule</description>
        </group>
        <group group_id="B2">
          <title>Naproxen/Normal Saline</title>
          <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion
Naproxen: Oral naproxen vs placebo
placebo: either normal saline or empty oral capsule</description>
        </group>
        <group group_id="B3">
          <title>Placebo Oral Medication/Lidocaine</title>
          <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion
Lidocaine: Intrauterine lidocaine vs normal saline
placebo: either normal saline or empty oral capsule</description>
        </group>
        <group group_id="B4">
          <title>Naproxen/Lidocaine</title>
          <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion
Naproxen: Oral naproxen vs placebo
Lidocaine: Intrauterine lidocaine vs normal saline</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="39"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="39"/>
            <count group_id="B4" value="39"/>
            <count group_id="B5" value="157"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="39"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="39"/>
                    <count group_id="B4" value="39"/>
                    <count group_id="B5" value="157"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="39"/>
                    <measurement group_id="B5" value="157"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="39"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="39"/>
                    <count group_id="B4" value="39"/>
                    <count group_id="B5" value="157"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="39"/>
                    <measurement group_id="B5" value="157"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="39"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="39"/>
                    <count group_id="B4" value="39"/>
                    <count group_id="B5" value="157"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="39"/>
                    <measurement group_id="B5" value="157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Control With IUD Insertion</title>
        <description>visual analog scale (0-10) as assessed by patient within 30 minutes after IUD insertion. Scale is from a minimum of 0, with maximum of 10 with higher scores denoting more pain</description>
        <time_frame>within 30 minutes after IUD insertion</time_frame>
        <population>There is one patient in placebo arm that did not receive IUD due to difficulty with insertion.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O2">
            <title>Naproxen/Normal Saline</title>
            <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion
Naproxen: Oral naproxen vs placebo
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O3">
            <title>Placebo Oral Medication/Lidocaine</title>
            <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion
Lidocaine: Intrauterine lidocaine vs normal saline
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O4">
            <title>Naproxen/Lidocaine</title>
            <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion
Naproxen: Oral naproxen vs placebo
Lidocaine: Intrauterine lidocaine vs normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Control With IUD Insertion</title>
          <description>visual analog scale (0-10) as assessed by patient within 30 minutes after IUD insertion. Scale is from a minimum of 0, with maximum of 10 with higher scores denoting more pain</description>
          <population>There is one patient in placebo arm that did not receive IUD due to difficulty with insertion.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="39"/>
                <count group_id="O4" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.606" spread=".372"/>
                    <measurement group_id="O2" value="3.088" spread=".367"/>
                    <measurement group_id="O3" value="2.83" spread=".372"/>
                    <measurement group_id="O4" value="3.382" spread=".372"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physician Perceived Pain Control During IUD Insertion</title>
        <description>visual analog scale (0-3) as assessed by physician within 30 minutes after IUD insertion Scale is from a minimum of 0, with maximum of 3 with higher scores denoting more pain</description>
        <time_frame>within 30 minutes after IUD insertion</time_frame>
        <population>There was one patient in placebo arm unable to have her IUD placed due to difficulty with insertion. She was removed from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O2">
            <title>Naproxen/Normal Saline</title>
            <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion
Naproxen: Oral naproxen vs placebo
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O3">
            <title>Placebo Oral Medication/Lidocaine</title>
            <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion
Lidocaine: Intrauterine lidocaine vs normal saline
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O4">
            <title>Naproxen/Lidocaine</title>
            <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion
Naproxen: Oral naproxen vs placebo
Lidocaine: Intrauterine lidocaine vs normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Physician Perceived Pain Control During IUD Insertion</title>
          <description>visual analog scale (0-3) as assessed by physician within 30 minutes after IUD insertion Scale is from a minimum of 0, with maximum of 3 with higher scores denoting more pain</description>
          <population>There was one patient in placebo arm unable to have her IUD placed due to difficulty with insertion. She was removed from the analysis.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="39"/>
                <count group_id="O4" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".59" spread=".8"/>
                    <measurement group_id="O2" value=".48" spread=".11"/>
                    <measurement group_id="O3" value=".56" spread=".09"/>
                    <measurement group_id="O4" value=".77" spread=".11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction With IUD</title>
        <description>Patient satisfaction as rated on a 1-5 scale 30 days post insertion. Scale of 5 means highly satisfied, 1 means unsatisfied.</description>
        <time_frame>30 days post insertion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O2">
            <title>Naproxen/Normal Saline</title>
            <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion
Naproxen: Oral naproxen vs placebo
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O3">
            <title>Placebo Oral Medication/Lidocaine</title>
            <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion
Lidocaine: Intrauterine lidocaine vs normal saline
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O4">
            <title>Naproxen/Lidocaine</title>
            <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion
Naproxen: Oral naproxen vs placebo
Lidocaine: Intrauterine lidocaine vs normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction With IUD</title>
          <description>Patient satisfaction as rated on a 1-5 scale 30 days post insertion. Scale of 5 means highly satisfied, 1 means unsatisfied.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="39"/>
                <count group_id="O4" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.423" spread=".16"/>
                    <measurement group_id="O2" value="4.325" spread=".145"/>
                    <measurement group_id="O3" value="4.264" spread=".153"/>
                    <measurement group_id="O4" value="4.358" spread=".147"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Difficulty IUD Insertion</title>
        <description>as rated by the physician. Very easy/easy were rated as &quot;easy&quot; whereas difficult/very difficult is difficult.</description>
        <time_frame>within 30 minutes of IUD insertion</time_frame>
        <population>Overall number of participants analyzed for placebo arm is different due to 1 of the subjects not able to have their IUD inserted due to difficulty of procedure. They were included in this analysis as an attempt had been made to insert device.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O2">
            <title>Naproxen/Normal Saline</title>
            <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion
Naproxen: Oral naproxen vs placebo
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O3">
            <title>Placebo Oral Medication/Lidocaine</title>
            <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion
Lidocaine: Intrauterine lidocaine vs normal saline
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O4">
            <title>Naproxen/Lidocaine</title>
            <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion
Naproxen: Oral naproxen vs placebo
Lidocaine: Intrauterine lidocaine vs normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Difficulty IUD Insertion</title>
          <description>as rated by the physician. Very easy/easy were rated as &quot;easy&quot; whereas difficult/very difficult is difficult.</description>
          <population>Overall number of participants analyzed for placebo arm is different due to 1 of the subjects not able to have their IUD inserted due to difficulty of procedure. They were included in this analysis as an attempt had been made to insert device.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="39"/>
                <count group_id="O4" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Easy</title>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="38"/>
                    <measurement group_id="O4" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Difficult</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Perceived Pain 30 Days Post Insertion</title>
        <description>survey patient 30 days later to determine her recollection of pain during insertion (0-10); 10 being the most pain. One patient had no IUD initially inserted and was not included; each arm had patients lost to follow up (3 in placebo arm, 2 in naproxen arm, 4 in placebo/oral medication arm).</description>
        <time_frame>30 days post IUD insertion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O2">
            <title>Naproxen/Normal Saline</title>
            <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion
Naproxen: Oral naproxen vs placebo
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O3">
            <title>Placebo Oral Medication/Lidocaine</title>
            <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion
Lidocaine: Intrauterine lidocaine vs normal saline
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O4">
            <title>Naproxen/Lidocaine</title>
            <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion
Naproxen: Oral naproxen vs placebo
Lidocaine: Intrauterine lidocaine vs normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Perceived Pain 30 Days Post Insertion</title>
          <description>survey patient 30 days later to determine her recollection of pain during insertion (0-10); 10 being the most pain. One patient had no IUD initially inserted and was not included; each arm had patients lost to follow up (3 in placebo arm, 2 in naproxen arm, 4 in placebo/oral medication arm).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="35"/>
                <count group_id="O4" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.12" spread=".40"/>
                    <measurement group_id="O2" value="2.97" spread=".43"/>
                    <measurement group_id="O3" value="3.2" spread=".48"/>
                    <measurement group_id="O4" value="3.04" spread=".42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Paragard vs Mirena IUD</title>
        <description>difference in pain ratings during IUD insertion as assessed by visual analog scale by both patient (0-10 with 10 being the most pain, 0 no pain) within 30 minutes post insertion classified by IUD type. This measure is made to address whether type of IUD affected pain perception.</description>
        <time_frame>visual analog scale as assessed by patient and physician both within 30 minutes post insertion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mirena</title>
            <description>All treatment arms that received this type IUD</description>
          </group>
          <group group_id="O2">
            <title>Paragard IUD</title>
            <description>All treatment arms</description>
          </group>
        </group_list>
        <measure>
          <title>Paragard vs Mirena IUD</title>
          <description>difference in pain ratings during IUD insertion as assessed by visual analog scale by both patient (0-10 with 10 being the most pain, 0 no pain) within 30 minutes post insertion classified by IUD type. This measure is made to address whether type of IUD affected pain perception.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.02" spread=".25"/>
                    <measurement group_id="O2" value="3.49" spread=".25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Paragard vs Mirena IUD Pain Medication Use</title>
        <description>Patient's recall of self administered pain medication within 24 hours after IUD insertion as reported 30 days post insertion. Denoted as &quot;yes &quot; or &quot;no&quot;. This measure was to assess whether any difference in pain perception between patients receiving different types of IUD.</description>
        <time_frame>30 days post insertion</time_frame>
        <population>These participants reflect the number of patients that were able to be successfully contacted approximately 30 days after their IUD insertion.</population>
        <group_list>
          <group group_id="O1">
            <title>Mirena Medication Use</title>
            <description>All treatment arms receiving mirena IUD</description>
          </group>
          <group group_id="O2">
            <title>Paragard</title>
            <description>All treatment arms receiving paragard IUD</description>
          </group>
        </group_list>
        <measure>
          <title>Paragard vs Mirena IUD Pain Medication Use</title>
          <description>Patient's recall of self administered pain medication within 24 hours after IUD insertion as reported 30 days post insertion. Denoted as &quot;yes &quot; or &quot;no&quot;. This measure was to assess whether any difference in pain perception between patients receiving different types of IUD.</description>
          <population>These participants reflect the number of patients that were able to be successfully contacted approximately 30 days after their IUD insertion.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Medication used postprocedure</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No medication use post procedure</title>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Paragard IUD Medication Use 30 Day Assessment</title>
        <description>Assessment of whether patient had used analgesics in first 24 hrs after Paragard IUD insertion. Quantified yes or no.</description>
        <time_frame>30 days</time_frame>
        <population>These participants reflect the number of patients that were able to be successfully contacted approximately 30 days after their IUD insertion.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O2">
            <title>Naproxen/Normal Saline</title>
            <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion
Naproxen: Oral naproxen vs placebo
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O3">
            <title>Placebo Oral Medication/Lidocaine</title>
            <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion
Lidocaine: Intrauterine lidocaine vs normal saline
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O4">
            <title>Naproxen/Lidocaine</title>
            <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion
Naproxen: Oral naproxen vs placebo
Lidocaine: Intrauterine lidocaine vs normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Paragard IUD Medication Use 30 Day Assessment</title>
          <description>Assessment of whether patient had used analgesics in first 24 hrs after Paragard IUD insertion. Quantified yes or no.</description>
          <population>These participants reflect the number of patients that were able to be successfully contacted approximately 30 days after their IUD insertion.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="18"/>
                <count group_id="O4" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes, used analgesics</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No medication use</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Assessment of Analgesic Use in Mirena IUD Patients Within 24 Hrs When Queried at Day 30</title>
        <description>Assessment at day 30 if patients used analgesics within 24 hrs post Mirena IUD insertion</description>
        <time_frame>30 days</time_frame>
        <population>These participants reflect the number of patients that were able to be successfully contacted approximately 30 days after their IUD insertion.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O2">
            <title>Naproxen/Normal Saline</title>
            <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion
Naproxen: Oral naproxen vs placebo
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O3">
            <title>Placebo Oral Medication/Lidocaine</title>
            <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion
Lidocaine: Intrauterine lidocaine vs normal saline
placebo: either normal saline or empty oral capsule</description>
          </group>
          <group group_id="O4">
            <title>Naproxen/Lidocaine</title>
            <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion
Naproxen: Oral naproxen vs placebo
Lidocaine: Intrauterine lidocaine vs normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Analgesic Use in Mirena IUD Patients Within 24 Hrs When Queried at Day 30</title>
          <description>Assessment at day 30 if patients used analgesics within 24 hrs post Mirena IUD insertion</description>
          <population>These participants reflect the number of patients that were able to be successfully contacted approximately 30 days after their IUD insertion.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="18"/>
                <count group_id="O4" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes, used analgesics</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No analgesics used</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Patient will receive placebo oral medication and intrauterine normal saline prior to IUD insertion
placebo: either normal saline or empty oral capsule</description>
        </group>
        <group group_id="E2">
          <title>Naproxen/Normal Saline</title>
          <description>Patient will receive naproxen and intrauterine normal saline prior to IUD insertion
Naproxen: Oral naproxen vs placebo
placebo: either normal saline or empty oral capsule</description>
        </group>
        <group group_id="E3">
          <title>Placebo Oral Medication/Lidocaine</title>
          <description>Patient will receive placebo oral medication and intrauterine lidocaine prior to IUD insertion
Lidocaine: Intrauterine lidocaine vs normal saline
placebo: either normal saline or empty oral capsule</description>
        </group>
        <group group_id="E4">
          <title>Naproxen/Lidocaine</title>
          <description>Patient will receive naproxen and intrauterine lidocaine prior to IUD insertion
Naproxen: Oral naproxen vs placebo
Lidocaine: Intrauterine lidocaine vs normal saline</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Sample size is limitation. Single site conducting study using single insurance payer.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Shana Miles</name_or_title>
      <organization>Walter Reed National Military Medical Center</organization>
      <phone>318 456 6389</phone>
      <email>shana.m.miles2.mil@mail.mil</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

